News and Announcements
Folkestone Maxim A-Reit Securities Fund Raises $564m Capital & Outperforms the Benchmark
- Published June 08, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Over the month, the Fund returned -0.58% (after fees, before tax) outperforming the Benchmark return of -1.00%. Over the 12-month period ended 31 May 2017, the Fund returned +6.48% (after fees, before tax), substantially outperforming the Benchmark return of +2.30% by +4.18%.
KEY TAKEAWAYS:
- During the month of May, a total of $564m of capital was raised.
- Charter Hall Group (CHC) raised $275m to co-invest in eight of its existing Funds, Aventus Retail Fund (AVN) raised $215m to acquire two large format retail assets in Sydney and Ingenia Group (INA) raised $74m to acquire five lifestyle communities.
- The vote for Investa Office Fund (IOF) to acquire a 50% interest in the Investa management platform failed, leaving Cromwell Property (CMW) now needing to clarify the status of its potential all cash offer to acquire all the units in IOF.
- In May, as expected, the Reserve Bank of Australia (RBA) left the cash rate unchanged at 1.5%. Key economic data released during the month again highlighted a mixed outlook with business confidence up, consumer confidence lower and a weaker retail environment.
- Retail sales in March fell a worse-than-expected 0.1%m/m (consensus: +0.3%) bringing the y/y rate to 2.1%, the slowest in almost four years.
- Residential building approvals for March also fell 10.3% as APRA continues to curb demand from investors.
- Some market commentators are now toying with a potential rate cut from the Reserve Bank if the weakness in the economy continues.
The A-REIT sector continues to benefit from the continued flow of foreign money chasing premium assets. This has led to further cap rate compression boosting their NTA’s. Also, some A-REIT managers are selling down non-core assets to reposition their portfolios and de-leverage their balance sheet.
Over the month, the Fund returned -0.58% (after fees, before tax) outperforming the Benchmark return of -1.00%. Over the 12 month period ended 31 May 2017, the Fund returned +6.48% (after fees, before tax), substantially outperforming the Benchmark return of +2.30% by +4.18%.
In May, positive contributions to returns came from the Fund’s overweight exposure to Eureka Group Holdings (EGH +5.3%) and Asia Pacific Data Centre (AJD +4.1%) and a zero holding in Stockland Group (SGP -2.7%).
Detracting from performance was the Fund’s overweight exposure to Folkestone Education Trust (FET -4.5%) and Rural Funds Group (RFF -3.5%).
At the end of May, the Fund’s investments comprised 16 ASX listed securities totalling 91.3% of the portfolio, 10 of which were constituents of the S&P/ASX 300 A-REIT Index, with the remaining 6 holdings being non-index stocks. A 0.1% exposure is held in an unlisted fund (a spin-off from GPT), which we expect to exit in due course. The balance of 8.6% of the portfolio was held in cash/liquid investments.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
